All IndicationsPhase 3Phase 3Phase 2Phase 2Phase 2Phase 2Phase 2Phase 2
Pruritus
2
Companies
8
Drug Programs
2
Phase 3
0
Upcoming PDUFAs
Competitors
VYNE
VYNE Therapeutics Inc.
Placebo Tablets
VYNE
VYNE Therapeutics Inc.
5mg Serlopitant Tablets
CARA
Cara Therapeutics, Inc.
difelikefalin 0.25 mg
CARA
Cara Therapeutics, Inc.
Part A: Placebo
CARA
Cara Therapeutics, Inc.
difelikefalin 2.0 mg
VYNE
VYNE Therapeutics Inc.
Serlopitant High Dose
VYNE
VYNE Therapeutics Inc.
Matching Placebo Tablets
VYNE
VYNE Therapeutics Inc.
5 mg Serlopitant Tablets
| Company | Drug | Phase | Designations | Timeline | Trial ID |
|---|---|---|---|---|---|
| VYNE VYNE Therapeutics Inc. | Placebo Tablets | Phase 3 | — | — | — |
| VYNE VYNE Therapeutics Inc. | 5mg Serlopitant Tablets | Phase 3 | — | — | — |
| CARA Cara Therapeutics, Inc. | difelikefalin 0.25 mg | Phase 2 | — | — | — |
| CARA Cara Therapeutics, Inc. | Part A: Placebo | Phase 2 | — | — | — |
| CARA Cara Therapeutics, Inc. | difelikefalin 2.0 mg | Phase 2 | — | — | — |
| VYNE VYNE Therapeutics Inc. | Serlopitant High Dose | Phase 2 | — | — | — |
| VYNE VYNE Therapeutics Inc. | Matching Placebo Tablets | Phase 2 | — | — | — |
| VYNE VYNE Therapeutics Inc. | 5 mg Serlopitant Tablets | Phase 2 | — | — | — |
Development Stage Distribution
Phase 3
2
Phase 2
6
PDUFA Timeline
No upcoming PDUFA dates for this indication.
Not Financial Advice
All predictions are probabilistic and based on historical data. Past performance does not guarantee future results. Consult a qualified financial advisor.